Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/01/2003US6541263 Determination of corticosteroids in human plasma using micromass LC/MS/MS
04/01/2003US6541262 Measuring clotting time when exposed to heparin in the presence and absence of antithrombin III
04/01/2003US6541260 Of wine, associated with acidity and cork taint; 2,4,6-trichloroanisole used as testing substance
04/01/2003US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections
04/01/2003US6541246 Method for detecting and for quantifying adenoviruses
04/01/2003US6541225 Methods and compositions for generating human monoclonal antibodies
04/01/2003US6541224 Protein for use in treatment, diagnosis and prevention of autoimmune disease
04/01/2003US6541220 Novel parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), receptors (PTH1R and PTH3R) isolated from zebrafish; vectors, host cells, recombinant methods for producing; use in identifying receptor agonists, antagonists
04/01/2003US6541216 Amperometric biosensor test strip
04/01/2003US6541215 Quantitative determination method of mannose and reagent therefor
04/01/2003US6541214 N-terminally truncated HER-2/neu protein as a cancer prognostic indicator
04/01/2003US6541213 Microscale diffusion immunoassay
04/01/2003US6541212 Anticancer agents
04/01/2003US6541211 Chemical compound solid phase synthesis utilizing arrays of solid phase supports which include hollow tubular-shaped lanterns and gears
04/01/2003US6541210 Viruses; bacteriophage; Hepatitis B; Hepatitis C; autoimmune disease; use to immunize an organism with a peptide that mimics an antigen or pathogenic organism specific to a disease
04/01/2003US6541209 Bioassay; identification of compounds as agonists; use in treatment of diseases and disorders that are related to 5-HT2A and or 5-HT2C serotonin receptors
04/01/2003US6541208 Measurement of Monocyte Chemoattractant Protein (MCP-1); HIV transactivator protein TAT; astrocytes; antagonists and inhibitors; use in treatment, prevention of HIV associated dementia
04/01/2003US6541206 By immunoassay detection and measurement of testis-specific HspA2 chaperone protein; use to determine sperm development, maturity, DNA integrity and fertilization potential
04/01/2003US6541203 Detecting structural or synthetic information about chemical compounds
04/01/2003US6541196 Method for cAMP production
04/01/2003US6541195 Exposing a cell that expresses a conformationally defective target protein with an amount of protein stabilizer selected from amino acids, polyols, dimethylsulfoxide and deuterated water that is effective to improve phenotypic defects
04/01/2003US6541194 Method for the detection of the presence of chemical species known to inhibit a chemiluminescent reaction
04/01/2003US6541193 Screening for nervous system modulators in fruit fliessample; obtain fruit flies, generate potassium channel mutants, culture flies, anesthetize flies with diethyl ether and monitor recovery time from anesthesia
04/01/2003US6541041 Crude drug extracts, and methods for making and standardizing same
04/01/2003US6541008 Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
04/01/2003US6541004 An immunogen comprising an antigenic protein bonded to at least one molecule of N-methyl tropane substituted at the 2-benzoyloxy group, which is substituted at para position with an aliphatic linking group of form 1-6 carbon atoms
04/01/2003US6540996 Compound screening methods
04/01/2003US6540992 Elk ligand (Elk-L) where elk is a member of the tyrosine kinase receptor family; protects against excitotoxicity, especially of the hipocammpal neurons
04/01/2003US6540980 Method of detecting endometriosis
04/01/2003US6540978 Inhibitors of the bitter taste response
04/01/2003US6540977 Cyanidin compositions and therapeutic and diagnostic uses therefor
04/01/2003US6540894 Phosphate ion selective electrode and manufacturing method thereof
04/01/2003US6540893 Ion sensor
04/01/2003US6540890 Biosensor
04/01/2003US6540691 Determining the presence or absence of aging in a mammal by analyzing samples of breath and air to determine content of n-alkanes, find differences in the alkane profile from the baseline alkane profile indicate aging
04/01/2003US6539781 Method and device for determining the hardness of products such as fruit
04/01/2003US6539780 Self-compensating tensiometer and method
04/01/2003US6539775 Method and apparatus for the measurement of the interchangeability of LPG/air mixtures with natural gas
04/01/2003US6539774 Thin film metal hydride hydrogen sensor
04/01/2003CA2290906C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
04/01/2003CA2254873C Electrochemical biosensors
04/01/2003CA2245108C Tandem fluorescent protein constructs
04/01/2003CA2021309C Method and materials for detecting pathology from alterations in estrogen metabolism
03/2003
03/28/2003CA2405139A1 A device for separating milk from a dairy animal
03/28/2003CA2404723A1 Methods related to the a-c repeat z-sequence upstream from the aldose reductase gene
03/27/2003WO2003029411A2 Novel cyclooxygenase variants and methods of use
03/27/2003WO2003025584A2 Direct serum lipids assays for evaluation of disease states
03/27/2003WO2003025583A2 Differential diagnosis of disorders of iron metabolism
03/27/2003WO2003025582A1 Improvements in or relating to detection of impaired fertility
03/27/2003WO2003025581A1 New landmarks and use thereof
03/27/2003WO2003025580A1 Parallel miniaturized quantitative immunoassays
03/27/2003WO2003025579A2 Use of heart fatty acid binding protein
03/27/2003WO2003025578A2 Concentration of protein and/or peptides samples
03/27/2003WO2003025577A2 Diagnosis and treatment of early pre-type 1 diabetes glial fibrillary acidic protein
03/27/2003WO2003025576A2 Mass labels
03/27/2003WO2003025575A1 Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance
03/27/2003WO2003025574A1 Embossed test strip system
03/27/2003WO2003025573A1 Multi-analyte assay device with multi-spot detection zone
03/27/2003WO2003025572A1 Arf and hdm2 interaction domains and methods of use thereof
03/27/2003WO2003025571A1 Diagnostic markers for ischemia
03/27/2003WO2003025569A1 Method of detecting cellular immunity and application thereof to drugs
03/27/2003WO2003025568A2 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation
03/27/2003WO2003025567A2 Production of support-bonded molecules by means of oligonucleotide tags
03/27/2003WO2003025566A2 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity
03/27/2003WO2003025565A2 Preparation of highly-purified plasma membranes
03/27/2003WO2003025564A1 Method for evaluating a patient's biological condition
03/27/2003WO2003025563A1 Method and a system for detecting and optionally isolating a rare event particle
03/27/2003WO2003025561A1 METHOD OF SIMULTANEOUSLY MEASURING Rb VALUE AND PLASMA PROTEIN-BINDING RATIO
03/27/2003WO2003025559A1 Measuring instrument, installation body, and density measurer
03/27/2003WO2003025554A2 Method quantitative video-microscopy and associated system and computer software program product
03/27/2003WO2003025545A1 Device and method for measuring mechanical properties of a material
03/27/2003WO2003025543A2 Methods of cytodiagnostic staging of neoplasia and squamous cell carcinoma
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025540A2 Differential tagging of polymers for high resolution linear analysis
03/27/2003WO2003025229A1 A method for identifying effector molecules for gene network integration
03/27/2003WO2003025228A1 Methods and compositions for treating hcap associated diseases
03/27/2003WO2003025224A1 Differential gene expression in schizophrenia
03/27/2003WO2003025222A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003WO2003025220A2 Fusion proteins useful for detecting analytes
03/27/2003WO2003025219A2 Method for sequencing nucleic acids
03/27/2003WO2003025218A2 Methods and yeast strains for screening antifungal agents
03/27/2003WO2003025217A1 Prognostic method
03/27/2003WO2003025216A1 Molecular typing of group b streptococci
03/27/2003WO2003025213A2 Yeast proteome analysis
03/27/2003WO2003025212A2 Method for detecting sepsis
03/27/2003WO2003025211A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003WO2003025210A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003WO2003025209A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003WO2003025208A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics
03/27/2003WO2003025207A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives
03/27/2003WO2003025205A2 Extracellular regulated kinase 2 (erk2)
03/27/2003WO2003025204A2 Biochip assembly, sensor assembly and method for operating a biochip assembly
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025192A2 Membrane transportable fluorescent substrates
03/27/2003WO2003025178A1 Novel protein and dna thereof
03/27/2003WO2003025168A1 Novel protein and dna thereof
03/27/2003WO2003025154A2 Methods and compositions for the construction and use of fusion libraries
03/27/2003WO2003025150A2 Lipid-associated molecules
03/27/2003WO2003025141A2 Genetic analysis for stratification of cancer risk
03/27/2003WO2003025140A2 Transductin-1 and transductin-2 and applications to hereditary deafness
1 ... 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 ... 3937